Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients

Respiratory Medicine

Volumn 105, Issue 4, 2011, Pages 519-525

  Watanabe, Tetsuya ^a   Asai, Kazuhisa ^a   Fujimoto, Hiroki ^a   Tanaka, Hidenori ^a   Kanazawa, Hiroshi ^a   Hirata, Kazuto ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Endogenous secretory receptor for advanced glycation end products; High mobility group box 1; Induced sputum; Neutrophilic inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE; NEUTROPHIL; PRIORITY JOURNAL; SPUTUM;

ADULT; ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HMGB1 PROTEIN; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; SPUTUM; YOUNG ADULT;

EID: 79952282593     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.10.016     Document Type: Article

References (41)

1. Jeffery PK. Remodering in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164: S28-38.
2. Panizza JA, James AL, Ryan G. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006;36(12):773-80. (Pubitemid 44691185)
3. Holgate ST. A need for circulating biomarkers of severe persistent asthma and its treatment. Clin Exp Allergy 2006; 36(11):1355-6. (Pubitemid 44674118)
4. Macdowell AL, Peters SP. Neutrophils in asthma. Curr Allergy Asthma Rep 2007;7(6):464-8. (Pubitemid 47629081)
5. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368 (9537):780-93. (Pubitemid 44279056)
6. Shaw DE, Berry MA, Hargadon B, et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007;132(6):1871-5.
7. Wen L, Huang JK, Johnson BH, et al. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 1989;17(3):1197-214. (Pubitemid 19062897)
8. Ferrari S, Fineli P, Rocchi M, et al. The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 1996;35(2): 367-71. (Pubitemid 26250324)
9. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285(5425):248-51. (Pubitemid 29329996)
10. Wang H, Vishnubhakat JM, Bloom O, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999;126(2):389-92. (Pubitemid 29382808)
11. Rendon-Mitchell B, Ochani M, Li J, et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003;170(7):3890-7. (Pubitemid 36361997)
12. Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101(7):2652-60. (Pubitemid 36857626)
13. Hamada N, Maeyama T, Kawaguchi T, et al. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2008;39(4):440-7.
14. Kalinina N, Agrotis A, Antropova Y, et al. Increased expression of the DNA-binding cytokine HMGB-1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004;24:2320-5. (Pubitemid 39658036)
15. Xiao XY, Lin L, Wen HP, et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009;205:544-8.
16. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intenal Med 2004;255:320-31. (Pubitemid 38324549)
17. Taira T, Matsuyama W, Mitsuyama H, et al. Increased serum high mobility group box-1 level in Churg-Strauss syndrome. Clin Exp Immunol 2007;148(2):241-7. (Pubitemid 46587592)
18. Shang GH, Jia CQ, Tian H, et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respir Med 2009;103(12):1949-53.
19. Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004;170(12):1310-6. (Pubitemid 39657195)
20. Hori O, Brett J, Slattery T, et al. RAGE is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995;270(43):25752-61.
21. Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992;267(21):14987-97.
22. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267(21):14998-5004.
23. Huttunen HJ, Fages C, Kuja-Panula J, et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002;62(16):4805-11.
24. Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. J Biol Chem 2003;370(Pt 3):1097-109. (Pubitemid 36399105)
25. Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25(12):2587-93. (Pubitemid 43732283)
26. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Novemver 1986. Am Rev Respir Dis 1987;136(1):225-44.
27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152(3):1107-36.
28. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160(6):2104-17.
29. Global Initiative for asthma management and Prevention-GINA. National Institutes Heart, Lung, and Blood Institute; 2006.
30. Paggiaro PL, Chanez P, Holz O, et al. Sputum induction. Eur Respir J Suppl 2002;37:3s-8s.
31. Kanazawa H, Asai K, Tochino Y, et al. Increased levels of angiopoietin-2 in induced sputum from smoking asthmatic patients. Clin Exp Allergy 2009;39(9):1330-7.
32. Kharitonov SA, Barnes PJ. Exhald markers of pulmonary disease. Am J Respir Crit Care Med 2001;163(7):1693-722.
33. Lemiere C, Ernst P, Olivenstein R, et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 2006;118(5):1033-9. (Pubitemid 44666987)
34. Tseliou E, Bessa V, Hillas G, et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010;138(1):107-13.
35. Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J, in press.
36. Huttunen HJ, Kuja-Panila J, Sorci G, et al. Coregultion of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000;275(51):40096-105. (Pubitemid 32064635)
37. Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001;152(6):1197-206. (Pubitemid 34280177)
38. Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in COPD. Am J Respir Crit Care Med 2010;181(9):917-27.
39. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143(6):1699-712. (Pubitemid 24058273)
40. Morbini P, Villa C, Campo I, et al. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 2006;19(11):1437-45.
41. Park JS, Arcaroli J, Yum HK, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol, Cell Physiol 2003;284(4):C870-879.